• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RSH
Click for more information
0.00% 8.0¢

RESPIRI LIMITED - Announcements

Market Cap $41.11M  ! watchlist Created with Sketch. Add to my watchlist

This should not be displayed since Corporate SPotlight is disabled. This should not be displayed since Corporate SPotlight is disabled.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
RSH Shareholder teleconference presentation28/03/19
RSH Shareholder conference call26/03/19
RSH Respiri progresses CE Mark registration22/03/19
RSH Company Secretary Appointment/Resignation13/03/19
RSH RESPIRI ANNOUNCES IR APPOINTMENT13/03/19
RSH Appendix 4D and Interim Financial Report - December 2018PRICE SENSITIVE27/02/19
RSH Medical Device Path To Market Update21/02/19
RSH Appendix 3B15/02/19
RSH Change of Director's Interest Notice11/02/19
RSH Cleansing Notice - Respiri Limited11/02/19
RSH Appendix 3B11/02/19
RSH Michael Clarke Kits Up For Respiri07/02/19
RSH Completion Of Share Purchase Plan OfferPRICE SENSITIVE04/02/19
RSH Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
RSH Auditor Change Finalised17/01/19
RSH Wheezo Exhibits at Consumer Electronics Show CES 201909/01/19
RSH Respiri's Share Purchase PlanPRICE SENSITIVE07/01/19
RSH $3.2M Share Placement Settlement21/12/18
RSH Share Purchase Plan - Indicative Timetable21/12/18
RSH Respiri Limited - Cleansing Notice21/12/18
RSH Appendix 3B21/12/18
RSH Respiri fast tracks industrial workplace asthma solution18/12/18
RSH Election of Chairman18/12/18
RSH $3.2M Share PlacementPRICE SENSITIVE18/12/18
RSH Significant strategic partnership for China distribution17/12/18
RSH Development Partners commit to take equity17/12/18
RSH Trading haltPRICE SENSITIVE14/12/18
RSH Initial Director's Interest Notice30/11/18
RSH Initial Director's Interest Notice30/11/18
RSH Results of 2018 Annual General Meeting28/11/18
RSH CEO Presentation - Annual General Meeting28/11/18
RSH Final Director Interest Notices27/11/18
RSH CHANGE OF RESPIRI BOARD OF DIRECTORS27/11/18
RSH Future Milestones Set For The Launch Of Wheezo13/11/18
RSH Shareholder Update - November 201813/11/18
RSH Shareholder Update09/11/18
RSH Appendix 4C and R&D Incentive AnnouncementPRICE SENSITIVE30/10/18
RSH Initial Director's Interest Notice26/10/18
RSH Annual Report to shareholders26/10/18
RSH Appendix 4G and Corporate Governance Statement26/10/18
RSH Notice of Annual General Meeting/Proxy Form26/10/18
RSH New Board Member Appointed24/10/18
RSH Product Naming Survey Confirms Market Demand19/10/18
RSH CEO 100 Day Update21/09/18
RSH Respiri Commercialisation Strategy Gathers Momentum21/09/18
RSH RESPIRI APPOINTS MANUFACTURING PARTNERPRICE SENSITIVE07/09/18
RSH Appendix 4E and Audited FY2018 Financial ReportPRICE SENSITIVE31/08/18
RSH Director Options Update10/08/18
RSH CEO Operational ReviewPRICE SENSITIVE30/07/18
RSH Appendix 4C - QuarterlyPRICE SENSITIVE30/07/18
RSH Directors Options06/07/18
RSH Appointment and Resignation of Company Secretary03/07/18
RSH New Chair appointed14/06/18
RSH Appendix 3Z - Final Director's Interest Notices (2)05/06/18
RSH Appendix 3X - Initial Director's Interest Notices (2)01/06/18
RSH Significant Milestone ProgressPRICE SENSITIVE30/05/18
RSH Changes to Respiri Board30/05/18
RSH Appendix 3Y - Change of Director's Interest Notice04/05/18
RSH Appendix 3Y - Change of Director's Interest Notice01/05/18
RSH Appendix 4C - quarterlyPRICE SENSITIVE30/04/18
RSH Respiri Accelerating Activity24/04/18
RSH Respiri Limited - Functional Prototype CompletedPRICE SENSITIVE20/04/18
RSH Respiri Limited - Cleansing Notice18/04/18
RSH Respiri Limited $3.0M Share Placement & Appendix 3B18/04/18
RSH RESPIRI LIMITED $3.0m SHARE PLACEMENTPRICE SENSITIVE10/04/18
RSH Trading Halt Request06/04/18
RSH Trading HaltPRICE SENSITIVE06/04/18
RSH CEO 100 Day Update05/03/18
RSH Half Year Announcement - February 201826/02/18
RSH Appendix 4D and Interim Financial Report - December 2017PRICE SENSITIVE26/02/18
RSH CEO Update and Reaffirmation of 2018 Plans and MilestonesPRICE SENSITIVE29/01/18
RSH Appendix 4C - quarterlyPRICE SENSITIVE29/01/18
RSH Appointment of Director & Board Remuneration22/12/17
RSH Appendix 3X - Initial Director's Interest Notice21/12/17
RSH Appendix 3Y - Change of Director's Interest Notices (x2)21/12/17
RSH Appendix 3X - Initial Director's Interest Notice21/12/17
RSH Appendix 3Z - Final Director's Interest Notice21/12/17
RSH Appendix 3B20/12/17
RSH Results of 2017 Annual General Meeting15/12/17
RSH 2017 AGM - Chairman's Address14/12/17
RSH AGM - Change of Venue & Start Time29/11/17
RSH 2017 Notice of Annual General Meeting and Proxy Form14/11/17
RSH AirSonea Generation 2 Breath Sensor Update30/10/17
RSH Appendix 4C - quarterlyPRICE SENSITIVE30/10/17
RSH Extension of Date for Annual General Meeting26/10/17
RSH Respiri Receives Notice of Intention17/10/17
RSH Respiri Appoints New Chief Executive OfficerPRICE SENSITIVE16/10/17
RSH Response to ASX Price QueryPRICE SENSITIVE11/10/17
RSH Breath Sensor Partnership with Grey Innovation CommencedPRICE SENSITIVE12/09/17
RSH Appendix 4E & Annual Financial Report (30 June 2017)PRICE SENSITIVE30/08/17
RSH Change of Registered Office11/08/17
RSH Respiri remains on track for commercialisation09/08/17
RSH Commencing the last step to commercialisationPRICE SENSITIVE27/07/17
RSH Appendix 4C - quarterlyPRICE SENSITIVE27/07/17
RSH Respiri & ChinaPRICE SENSITIVE30/05/17
RSH Company Secretary Appointment/Resignation17/05/17
RSH Executive Chair Remuneration Update17/05/17
RSH Appendix 4C - QuarterlyPRICE SENSITIVE27/04/17
RSH Partner Discussions EncouragingPRICE SENSITIVE27/04/17
RSH European CE Mark Approval ReceivedPRICE SENSITIVE12/04/17
RSH Shareholder teleconference presentation
28/03/19
RSH Shareholder conference call
26/03/19
RSH Respiri progresses CE Mark registration
22/03/19
RSH Company Secretary Appointment/Resignation
13/03/19
RSH RESPIRI ANNOUNCES IR APPOINTMENT
13/03/19
RSH Appendix 4D and Interim Financial Report - December 2018
27/02/19PRICE SENSITIVE
RSH Medical Device Path To Market Update
21/02/19
RSH Appendix 3B
15/02/19
RSH Change of Director's Interest Notice
11/02/19
RSH Cleansing Notice - Respiri Limited
11/02/19
RSH Appendix 3B
11/02/19
RSH Michael Clarke Kits Up For Respiri
07/02/19
RSH Completion Of Share Purchase Plan Offer
04/02/19PRICE SENSITIVE
RSH Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
RSH Auditor Change Finalised
17/01/19
RSH Wheezo Exhibits at Consumer Electronics Show CES 2019
09/01/19
RSH Respiri's Share Purchase Plan
07/01/19PRICE SENSITIVE
RSH $3.2M Share Placement Settlement
21/12/18
RSH Share Purchase Plan - Indicative Timetable
21/12/18
RSH Respiri Limited - Cleansing Notice
21/12/18
RSH Appendix 3B
21/12/18
RSH Respiri fast tracks industrial workplace asthma solution
18/12/18
RSH Election of Chairman
18/12/18
RSH $3.2M Share Placement
18/12/18PRICE SENSITIVE
RSH Significant strategic partnership for China distribution
17/12/18
RSH Development Partners commit to take equity
17/12/18
RSH Trading halt
14/12/18PRICE SENSITIVE
RSH Initial Director's Interest Notice
30/11/18
RSH Initial Director's Interest Notice
30/11/18
RSH Results of 2018 Annual General Meeting
28/11/18
RSH CEO Presentation - Annual General Meeting
28/11/18
RSH Final Director Interest Notices
27/11/18
RSH CHANGE OF RESPIRI BOARD OF DIRECTORS
27/11/18
RSH Future Milestones Set For The Launch Of Wheezo
13/11/18
RSH Shareholder Update - November 2018
13/11/18
RSH Shareholder Update
09/11/18
RSH Appendix 4C and R&D Incentive Announcement
30/10/18PRICE SENSITIVE
RSH Initial Director's Interest Notice
26/10/18
RSH Annual Report to shareholders
26/10/18
RSH Appendix 4G and Corporate Governance Statement
26/10/18
RSH Notice of Annual General Meeting/Proxy Form
26/10/18
RSH New Board Member Appointed
24/10/18
RSH Product Naming Survey Confirms Market Demand
19/10/18
RSH CEO 100 Day Update
21/09/18
RSH Respiri Commercialisation Strategy Gathers Momentum
21/09/18
RSH RESPIRI APPOINTS MANUFACTURING PARTNER
07/09/18PRICE SENSITIVE
RSH Appendix 4E and Audited FY2018 Financial Report
31/08/18PRICE SENSITIVE
RSH Director Options Update
10/08/18
RSH CEO Operational Review
30/07/18PRICE SENSITIVE
RSH Appendix 4C - Quarterly
30/07/18PRICE SENSITIVE
RSH Directors Options
06/07/18
RSH Appointment and Resignation of Company Secretary
03/07/18
RSH New Chair appointed
14/06/18
RSH Appendix 3Z - Final Director's Interest Notices (2)
05/06/18
RSH Appendix 3X - Initial Director's Interest Notices (2)
01/06/18
RSH Significant Milestone Progress
30/05/18PRICE SENSITIVE
RSH Changes to Respiri Board
30/05/18
RSH Appendix 3Y - Change of Director's Interest Notice
04/05/18
RSH Appendix 3Y - Change of Director's Interest Notice
01/05/18
RSH Appendix 4C - quarterly
30/04/18PRICE SENSITIVE
RSH Respiri Accelerating Activity
24/04/18
RSH Respiri Limited - Functional Prototype Completed
20/04/18PRICE SENSITIVE
RSH Respiri Limited - Cleansing Notice
18/04/18
RSH Respiri Limited $3.0M Share Placement & Appendix 3B
18/04/18
RSH RESPIRI LIMITED $3.0m SHARE PLACEMENT
10/04/18PRICE SENSITIVE
RSH Trading Halt Request
06/04/18
RSH Trading Halt
06/04/18PRICE SENSITIVE
RSH CEO 100 Day Update
05/03/18
RSH Half Year Announcement - February 2018
26/02/18
RSH Appendix 4D and Interim Financial Report - December 2017
26/02/18PRICE SENSITIVE
RSH CEO Update and Reaffirmation of 2018 Plans and Milestones
29/01/18PRICE SENSITIVE
RSH Appendix 4C - quarterly
29/01/18PRICE SENSITIVE
RSH Appointment of Director & Board Remuneration
22/12/17
RSH Appendix 3X - Initial Director's Interest Notice
21/12/17
RSH Appendix 3Y - Change of Director's Interest Notices (x2)
21/12/17
RSH Appendix 3X - Initial Director's Interest Notice
21/12/17
RSH Appendix 3Z - Final Director's Interest Notice
21/12/17
RSH Appendix 3B
20/12/17
RSH Results of 2017 Annual General Meeting
15/12/17
RSH 2017 AGM - Chairman's Address
14/12/17
RSH AGM - Change of Venue & Start Time
29/11/17
RSH 2017 Notice of Annual General Meeting and Proxy Form
14/11/17
RSH AirSonea Generation 2 Breath Sensor Update
30/10/17
RSH Appendix 4C - quarterly
30/10/17PRICE SENSITIVE
RSH Extension of Date for Annual General Meeting
26/10/17
RSH Respiri Receives Notice of Intention
17/10/17
RSH Respiri Appoints New Chief Executive Officer
16/10/17PRICE SENSITIVE
RSH Response to ASX Price Query
11/10/17PRICE SENSITIVE
RSH Breath Sensor Partnership with Grey Innovation Commenced
12/09/17PRICE SENSITIVE
RSH Appendix 4E & Annual Financial Report (30 June 2017)
30/08/17PRICE SENSITIVE
RSH Change of Registered Office
11/08/17
RSH Respiri remains on track for commercialisation
09/08/17
RSH Commencing the last step to commercialisation
27/07/17PRICE SENSITIVE
RSH Appendix 4C - quarterly
27/07/17PRICE SENSITIVE
RSH Respiri & China
30/05/17PRICE SENSITIVE
RSH Company Secretary Appointment/Resignation
17/05/17
RSH Executive Chair Remuneration Update
17/05/17
RSH Appendix 4C - Quarterly
27/04/17PRICE SENSITIVE
RSH Partner Discussions Encouraging
27/04/17PRICE SENSITIVE
RSH European CE Mark Approval Received
12/04/17PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $41.11M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 7063 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 43028 1
View Market Depth
Last trade - 16.12pm 22/11/2024 (20 minute delay) ?
RSH (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.